Volume 2, Issue 24: CIRM, Largest Funder of Stem Cell Research in the US, Accelerating Research to Meet Patient Needs

Dear Colleagues:

In this issue we were able to speak with Kevin McCormack, Sr. Director Public Communications & Patient Advocate Outreach, California Institute for Regenerative Medicine, the state of California’s stem cell agency.

This state agency, created by the voters of California in 2004 and given $3 billion to fund stem cell research is playing a huge role in the curing of fatal diseases.

This issue also brings you, the announcement of Cleveland Clinic’s new CEO, how large employers are increasingly leaning on value-based contracts and the CDC’s take on opioid prescription numbers.

Tell us:

What distinguishes your service offering in terms of cost, patient experience and satisfaction, outcomes, or other quality indicators.

Send us your descriptor, including photos or charts, and we will evaluate for publication in this newsletter.

“Rising health insurance premiums, lack of transparency and increased awareness of how varied medical costs and quality vary dramatically between hospitals and across regions, have pushed consumers right into the arms of international and domestic medical travel. The growing industry provides the perfect solution for patients to receive the high-quality, cost-effective care that they need AND rightfully deserve!” – Laura Carabello, Executive Editor and Publisher, Medical Travel Today and U.S. Domestic Medical Travel.

Thank you for your interest in this exciting, growing market space. We welcome your comments and/or editorial contributions, which can be sent directly to: editor@USDomesticMedicalTravel.com.

Laura Carabello
Editor and Publisher

Leave a Reply